US Rep. Rosa DeLauro has introduced a bill calling for a three-year moratorium on advertising newly approved prescription drugs directly to consumers.
The bill, known as the Responsibility in Drug Advertising Act, would also prohibit ads from running after the three-year moratorium if the Department of Health and Human Services determines the drug generated “significant” side effects based on studies, scientific literature, and other data. It was introduced by Rep. Rosa DeLauro (D-Conn.).
The legislation, which is designed to amend the federal Food, Drug, and Cosmetic Act, is only the latest effort to squelch direct-to-consumer advertising of prescription medicines. Three months ago, the American Medical Association called for an outright ban on this form of promotion (here).
Like the AMA, DeLauro also argued that advertising can inflate health care costs if consumers are prompted to seek newer, higher-priced medicines that drug makers may advertise to quickly trigger sales.